Lannett Company Inc (LCI)

LCI on New York Consolidated

5 Feb 2016
Change (% chg)

$-1.91 (-7.15%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for LCI


Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company's products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital products, Ursodiol capsules and pain management products. Levothyroxine Sodium tablets are produced and marketed with... (more)


Beta: 2.17
Market Cap(Mil.): $904.87
Shares Outstanding(Mil.): 36.46
Dividend: --
Yield (%): --


  LCI Industry Sector
P/E (TTM): 7.93 31.76 38.72
EPS (TTM): 3.13 -- --
ROI: 11.78 15.12 14.47
ROE: 25.17 15.85 15.40
Search Stocks

Lannett to buy UCB unit to boost specialty generic drugs portfolio

Lannett Co Inc said it would buy Kremers Urban Pharmaceuticals Inc, a U.S. unit of Belgian drugmaker UCB SA , for $1.23 billion to expand its specialty generic drugs portfolio.

02 Sep 2015

UPDATE 2-Lannett to buy UCB unit to boost specialty generic drugs portfolio

* Lannett shares rise about 17 pct after market (Adds details from conference call; updates shares)

02 Sep 2015

Drugmaker Lannett to buy UCB unit Kremers Urban for $1.23 bln

Sept 2 Drugmaker Lannett Co Inc said it would buy specialty generic drug maker Kremers Urban Pharmaceuticals Inc for $1.23 billion to expand its product portfolio.

02 Sep 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
Provider : ValuEngine, Inc.
Provider : Pechala's Reports
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks